...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: TNBC no longer active?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Just spitballing, but maybe it's because there's now an approved drug for that same indication, the FDA will no longer accept a phase 2 as registration enabling.

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply